Suchergebnisse - "Colman, Ruben J"

PubPharm (29)

1

Operating Properties of Disease Activity Indices in Pediatric Inflammatory Bowel Disease : A Systematic Review

enthalten in: Inflammatory bowel diseases | 2024

von Colman, R. | Solitano, V. | MacDonald, J. | +4

2

Precise infliximab exposure and pharmacodynamic control to achieve deep remission in paediatric Crohn's disease (REMODEL-CD) : study protocol for a multicentre, open-label, pragmatic clinical trial in the USA

enthalten in: BMJ open | 2024

von Minar, P. | Colman, R. | Zhang, N. | +2

3

Infliximab Monotherapy vs Combination Therapy for Pediatric Crohn's Disease Exhibit Similar Pharmacokinetics

enthalten in: Inflammatory bowel diseases | 2024

von Colman, R. | Vuijk, S. | Mathôt, R. | +6

4

HLA-DQA1∗05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists : A Systematic Review and Meta-analysis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Solitano, V. | Facciorusso, A. | McGovern, D. | +11

CommentIn: Clin Gastroenterol Hepatol. 2024 Jan;22(1):200-201. - PMID 37211267

5

Model-informed Precision Dosing for Biologics Is Now Available at the Bedside for Patients With Inflammatory Bowel Disease

enthalten in: Inflammatory bowel diseases | 2023

von Colman, R. | Samuels, A. | Mizuno, T. | +3

6

Editorial : achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease-authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Colman, R. | Minar, P.

CommentOn: Aliment Pharmacol Ther. 2023 Mar;57(5):565-566. - PMID 36786458

7

Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Colman, R. | Mizuno, T. | Fukushima, K. | +12

CommentIn: Aliment Pharmacol Ther. 2023 Mar;57(5):565-566. - PMID 36786458

8

Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance

enthalten in: Alimentary Pharmacology & Therapeutics | 2023

von Colman, R. | Mizuno, T. | Fukushima, K. | +12

9

Editorial : achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease—authors' reply

enthalten in: Alimentary Pharmacology & Therapeutics | 2023

von Colman, R. | Minar, P.

10

Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Colman, R. | Xiong, Y. | Mizuno, T. | +11

CommentIn: Aliment Pharmacol Ther. 2022 Apr;55(7):885-886. - PMID 35315101